Abstract. Congenital central hypothyroidism (C-CH) is a rare disease known to be caused by mutations of the genes encoding TSH β or the TRH receptor gene, although the cause of the disease in a number of patients has not yet been clarified. Recently, mutations and deletions of the immunoglobulin superfamily member 1 (IGSF1) gene have been reported to be the cause of C-CH. Here we report a Japanese male patient with C-CH due to a novel IGSF1 mutation. He was detected by neonatal mass screening of simultaneous TSH and free T4 measurements and levothyroxine was initiated. At 6 years of age he underwent 123 I scintigraphy after levothyroxine treatment had been discontinued for one month and his thyroid and pituitary function were evaluated. Since TSH and PRL responses after TRH stimulation were low, his diagnosis of C-CH was confirmed. During follow up, whereas onset of his puberty was delayed, his secondary sex characterization completed at 17 years old. In this patient we analyzed IGSF1 and TRHR. As results, we identified a novel insertion mutation in IGSF1 (c.3528-3529insC), resulting in a premature stop codon (p.Pro1082Trpfs39X). In conclusion, we identified a novel mutation of IGSF1 in a Japanese male patient with C-CH.
CongenitAl CentrAl hypothyroidism (C-CH) is an unusual condition characterized by low levels of both thyroid hormones and of thyroid-stimulating hormone (TSH) [1, 2] . Patients with this disorder are not detected by neonatal screening programs based on TSH measurements, which is frequently in the low to normal range. However, this type of CH has been identified by neonatal screening for CH on the basis of thyroxine (T4) or free T4 and TSH concentrations [1] [2] [3] .
Isolated C-CH remains a rare disease and is due mainly to genetic deficit of the β-subunit of TSH (OMIM 188540) or the thyrotropin-releasing hormone (TRH) receptor (OMIM 188545) mutations [4] [5] [6] [7] [8] [9] . Most recently, mutations and deletions of human immunoglobulin superfamily gene 1 (IGSF1) have been reported in X-linked C-CH [10] . IGSF1 encodes a plasma membrane immunoglobulin super family glycoprotein , containing twelve C2 type immunoglobulin loops, a transmembrane domain, and a short intracellular C terminal domain [11] [12] [13] . It has been shown that human IGSF1 and mouse Igsf1 are highly expressed in Rathke's pouch and adult pituitary gland and testis [10, 12] . In addition, Igsf1 protein is expressed in mouse thyrotropes, somatotropes and lactotropes, but not in gonadotropes [10] .
In this study, we report a Japanese male patient with C-CH, who was identified by a neonatal mass screening and a novel IGSF1 mutation in this patient.
methods

Neonatal CH screening
The neonatal CH screening program in Sapporo was based on simultaneous TSH and free T4 measurement in dried blood on filter paper specimens [3, 14] . Dried blood samples on filter paper are collected from neonatal infants born in Sapporo City at 4-6 days of age from maternity and parturition clinics to Sapporo City Institute of Health. TSH and free T4 were measured simultaneously on blood spots on filter paper. TSH and free T4 were measured by ELISA kits (Bayer Medical Enzaplate Neo-TSH and Enzplate N-FT4 kits, Japan).
To detect the severe CH, children with TSH con- Table 1) . He was thought to have C-CH and levothyroxine was initiated. Thereafter, the dose of levothyroxine was gradually increased and 70 µg/day was required to maintain serum FT4 within the normal range at 6 years of age. At 6 years of age he underwent 123 I scintigraphy after levothyroxine treatment had been discontinued for one month and his thyroid and pituitary function were evaluated. The scintigraph was a normal size of thyroid gland and uptake centrations more than or equal to 50 mU/L and/or free T4 less than < 0.5 ng/dL were directly referred to the expert hospital. Second heel puncture was requested if one of the following criteria for recall testing was met: (1) free T4 < 1.0 ng/dL, (2) high TSH concentration (>10 mU/L). Infants whose TSH or free T4 in the second testing were successively out of the normal range were sent to the expert hospital. We previously reported the frequency of C-CH in Sapporo [3] .
Pituitary hormone stimulation test
Serum levels of TSH and prolactin (PRL) were determined in response to TRH (5µg/kg). GH provocative tests were performed using insulin (0.1 IU/kg). Serum levels of LH and FSH were determined in response to GnRH (2µg/kg).
Genetic studies
Our institutional ethics committee approved the study, and the patients' parents provided written informed consent.
Sequence analysis of IGSF1
Genomic DNA was extracted from peripheral blood leukocytes. Exon and exon-intron boundaries of IGSF1 were amplified by polymerase chain reaction (PCR) using primers as reported previously [10] . After amplification, PCR products were purified and sequenced directly with an ABI PRISM Dye Terminator Cycle Kit and an ABI 373A automated fluorescent sequencer (PE Applied Biosystems, Foster City, CA). In addition to IGSF1, TRHR was also sequenced according to a reported study [9] .
Case report
Patient, now a 21-year old Japanese boy, was born after 39 weeks of gestation by normal vaginal delivery in Sapporo city and was the third child of nonconsanguineous parents. His parents were healthy. His growth is shown in Fig. 1 . There was no family history of thyroid disease. His birth weight was 3,528 g and his length was 50 cm. Neonatal mass screening for CH showed blood TSH = 1.7 mU/L, and FT4 = 0.75 ng/dL at 5 days of age. Because of this result, he was requetsed for the second sample of blood filter paper and the second smaple was taken at 16 days of age. The results of the second sample were as follows; TSH=0.6 mU/L and FT4=0.51 ng/dL (Table 1) . Since he was suspected 
results
Sequence analysis of IGSF1 demonstrated one base insertion mutation in exon 16 (c.3528-3529insC) ( Fig. 2A) . Neither one hundred normal Japanese subjects had this base insertion. This insertion mutation changes an open reading frame, resulting in a premature codon 39 bases downstream from the insertion portion (p.Pro1082Trpfs39X). The location of mutations reported and the mutation identified in this study are shown in Fig. 2 . Sequencing of TRHR did not show any mutation.
Since his parents did not want DNA analysis, the inheritance was not unknown. was 31% at 24 hr. Results of stimulation test are summarized in Table 2 . Serum TSH exhibited low values in response to TRH stimulation. TSH was 2.45 mU/L before, 5.17 mU/L at 60 min. Basal FT4 and FT3 were 0.35 ng/dL and 1.52 pg/mL, respectively (normal range for this age, FT4, 1.11-1.58 ng/dL and FT3, 5.1-3.90 pg/mL, respectively). Serum PRL also showed a low response to TRH stimulation (from 0.25 to 1.18 ng/ mL). GH increased from 1.0 to 6.3 ng/mL after insulin tolerance test. GnRH test showed a normal response of LH and FSH for his age (LH, <0.1 to 1.17IU/L, and FSH 0.30 to 4.1 IU/L). Brain MRI was normal, including the hypothalamic-pituitary region.
Thereafter, levothyroxine replacement continued. During follow up, whereas onset of his puberty was delayed, his serum LH and FSH gradually elevated since 14 years old, and his secondary sex characterization completed at 17 years old. Now he is 21 years old. His height is 170cm, and his body weight is 64 kg. His pubic hair is Tanner stage 4. His right and left testicu- responses of serum TSH levels after TRH test in evaluate patients were low, in agreement with our study [10] . In addition, reduced TSH synthesis and secretion were observed in Igsf1 knockout mice. Taken together, impaired TRH signaling is likely to be one of causes of the development of C-CH [10] . It is of note that the patient showed fairy high 123 I uptake and a normal sized thyroid. A previous report of IGSF1 mutations did not mention about the size of thyroid [10] . Compared to our patient, thyroid was hypoplasia in patients with TSHB mutations [16] .Thus, TSH deficiency or inactivity typically results in a thyroid gland that is normally located, but hypoplastic. However, despite persistently undetectable TSH levels, normal 123 I thyroid uptake in two adult patients with goiter was reported [17] . The exact reason for this and our finding is not determined, but unknown factor may have a role for thyroid morphogenesis after birth.
Our patient also showed low serum levels of PRL. This finding is concordant with a previous report.
Regarding pubertal development, in 10 out of 11 evaluable patients, more than 2 years delay of puberty was observed [10] . Moreover, it is of note that in adolescence and adult patients, macroorchidism was discussion In this study, we identified a novel mutation of IGSF1 in the patient with C-CH, who was detected by neonatal mass screening. In the first report, neonatal screening for CH determining TSH and T4 has detected seven familial cases [10] . These findings indicate that neonatal screening for CH determining TSH and T4 is able to detect patients with IGSF1 mutations.
To date, two deletions and eight mutations of IGSF1 have been reported in 11 families with X-linked C-CH (Fig. 3) [10] . Of these mutations, two were a nonsense mutations (p.Trp977X and p. Trp1173X), and two frame shift mutations produced premature stop codon (p.Glu750LysfsX28 and p.Glu1200RfsX). Others were amino acid substitutions (p.Ala713_Lys721 del, p. Ser863Phe, p.Cys947Arg and p.Ser770Asn). In vitro functional study of these amino acid changes demonstrated that these mutants were loss of function. Since our mutation produced a premature stop codon in exon16, mRNA from this allele might be subjected to nonsense mediated decay [15] .
In our patient, TRH stimulation test at 6 years of age showed a low response of TSH. In a previous study, testicular development and maturation from childhood to adult. This must be further studied.
In conclusion, we identified a novel mutation of IGSF1 in a Japanese male patient with C-CH.
observed [10] . However, 6 patients with macroorchidism had fertility. Whereas the exact mechanism of delayed puberty and macroorchidism is unknown, IGSF1 is expressed in testis [10, 12] . Therefore, it is speculated that IGSF1 may play some role in human references
